This month, we had the honor of welcoming Lehendakari Imanol Pradales and key members of his government team to our facilities; Mikel Jauregi, Minister of Industry, Energy Transition and Sustainability; Juan Ignacio Pérez Iglesias, Minister of Science, University, and Innovation; and Jaione Ganzarain, Deputy Minister of Technology, Innovation, and Digital Transformation.
During their visit, we had the opportunity to share Viralgen’s mission of bringing advanced treatments to those who need them most, to showcase the science that takes place in our laboratories and give insights on AAVs (Adeno-Associated Virus vectors) manufacturing process, critical to gene therapies.
We are deeply grateful to have hosted these important visitors/ stakeholders and appreciate the continuous support critical for developing innovative therapies in the Basque country. This visit strengthens our commitment to health and innovation, as we work together to advance progress in the field of gene therapies.
News
September 26, 2024
Visit of Lehendakari Imanol Pradales and his team to Viralgen facilities: A step forward in advancing gene therapies
Explore more

News
Viralgen and CTNNB1 Foundation partner to manufacture a new gene therapy for CTNNB1 Syndrome
Patients with CTNNB1 Syndrome will benefit from this joint effort to develop and manufacture a new AAV investigational gene therapy, which aims to restore gene function and may improve quality of life. San Sebastián, Spain and Ljubljana, Slovenia,...
READ MORE
February 05, 2025

Insights
Digital Transformation at Viralgen
The article, written by María Iglesias, Digital & IT Head at Viralgen, explores how digitalization has transformed the manufacturing processes of adeno-associated viral (AAV) vectors at the company. Viralgen specializes in producing these viruses...
READ MORE
January 29, 2025

News
Viralgen and Axovia Partner to Manufacture an Investigational Gene Therapy for Retinal Dystrophy in Bardet-Biedl Syndrome (BBS) Patients
Collaborative effort will bring hope to BBS patients suffering from retinal degeneration through this investigational gene therapy. San Sebastián, Spain and London, Great Britain (January 22, 2025) - Viralgen and Axovia Therapeutics announced today...
READ MORE
January 22, 2025